1-11 of 11
What Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Medical Industry FeatureWhat Is on the ‘HERIZON’ in 1L HER2+ Gastroesophageal Adenocarcinoma?
Jennifer Caudle, DO, FACOFP
Syma Iqbal, MD
Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research
Howard Fine, M.D.
Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Project Oncology®Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Brian P. McDonough, MD, FAAFP
Brooke Adams, PharmD, BCOP
BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Sharyn N. Lewin, MD, FACS, FACOG
Dana Chase, MD
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH
- advertisement
Evolving Treatment Approaches in EGFRm NSCLC
Medical Industry FeatureEvolving Treatment Approaches in EGFRm NSCLC
Jennifer Caudle, DO, FACOFP
Hossein Borghaei, MS, DO
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry FeatureNew Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Brian Gill, M.D.
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry FeatureRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Joel Gabre, M.D, MPH
An Exploration of Multiple Myeloma Treatments
Project Oncology®An Exploration of Multiple Myeloma Treatments
Key Considerations for G-CSF Administration in Patients with FN Risk
Medical Industry FeatureKey Considerations for G-CSF Administration in Patients with FN Risk
Charles Turck, PharmD, BCPS, BCCCP
Arielle Heeke, MD
- advertisement